Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adenosine deaminase domain-containing protein 1 (ADAD1) is a testis-specific RNA-binding protein containing a double-stranded RNA-binding motif and an adenosine deaminase domain; however, its AD domain is catalytically inactive and does not perform RNA editing. Instead, ADAD1 regulates the translation and localization of mRNAs and associated proteins during spermatid development. Loss of ADAD1 causes defective sperm morphology, impaired DNA compaction, abnormal head shaping, reduced motility, and male infertility. The protein is essential for normal differentiation of male germ cells, with roles in nuclear pore complex, LINC complex, manchette structure, and overall regulation of spermiogenesis. It is not currently considered a receptor, enzyme, or therapeutic target, but is crucial for fertility biology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenosine deaminase domain-containing protein 1 (ADAD1).